Header Logo

Connection

JASON ROBERT WESTIN to Pyrazines

Back to Details
This is a "connection" page, showing publications JASON ROBERT WESTIN has written about Pyrazines.
JASON ROBERT WESTIN
Connection Strength
0.031
Pyrazines
  1. Clinicopathological characteristics, outcomes and pattern of mutations in patients with follicular lymphoma who progressed on Bruton tyrosine kinase inhibitors. Br J Haematol. 2018 09; 182(5):718-723.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.